| 000 | 00861 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250518061402.0 | ||
| 264 | 0 | _c20200421 | |
| 008 | 202004s 0 0 eng d | ||
| 022 | _a1360-0443 | ||
| 024 | 7 |
_a10.1111/add.14826 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStreel, Emmanuel | |
| 245 | 0 | 0 |
_aResponse to Darke et al. (2019): Circumstances of death of opioid users being treated with naltrexone. _h[electronic resource] |
| 260 |
_bAddiction (Abingdon, England) _c02 2020 |
||
| 300 |
_a384 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aAnalgesics, Opioid |
| 650 | 0 | 4 | _aNaltrexone |
| 650 | 0 | 4 | _aNarcotic Antagonists |
| 700 | 1 | _aBrewer, Colin | |
| 773 | 0 |
_tAddiction (Abingdon, England) _gvol. 115 _gno. 2 _gp. 384 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/add.14826 _zAvailable from publisher's website |
| 999 |
_c30116712 _d30116712 |
||